New research has led to FDA approval of the use of a drug to treat the effects of radiation exposure following a nuclear incident. The drug, Neupogen, is the first ever approved for the treatment of acute radiation injury.
from Today's Healthcare News -- ScienceDaily http://ift.tt/1HqGIGD
No comments:
Post a Comment